SCN1A upregulation can be achieved by blocking the transcriptional inhibitory activity of a regulatory lncRNA from the SCN1A locus (SCN1ANAT) using 2OMe ASOs termed AntagoNATs (Alzheimer’s Disease). This evidence concerns the gene SCN1A and Alzheimer disease.